indexo.dev

pharmablock.com

.com crawl

First seen 2026-04-29 · Last seen 2026-05-07 · ok HTTP/1.1 200 3174 ms crawled 2026-05-07

US · 47.254.47.94 · AS45102 Alibaba US Technology Co., Ltd.

Reputation 95/100 weak security headers

Classifying

HTML metadata

Title
PharmaBlock USA Inc
Description
南京药石科技股份有限公司（公司简称：药石科技，股票代码：300725.SZSE）是全球药物研发领域创新型化学产品和服务供应商。主营业务包括药物分子砌块的研发、工艺开发、生产和销售；药物分子砌块驱动的药物发现化合物库；药物分子砌块下游关键中间体、原料药和制剂的工艺研究、开发和生产服务。
Language
zh-CN

Open Graph

title
南京药石科技股份有限公司
site name
南京药石科技股份有限公司
description
南京药石科技股份有限公司（股票代码：300725，公司简称：药石科技）是全球医药研发和制造领域一站式创新产品和服务供应商。公司始终致力于通过研发和生产过程中的化学和低碳技术的创新，帮助合作伙伴提高新药发现及开发效率，全速推进项目上市进程。自2008年开始运营以来，药石科技已与几乎所有全球排名前二十的制药公司及数百家中小型生物技术公司达成合作

Technology

Server
nginx
CMS
Nuxt

Contact

Address
st newsSubmitCopyright © 2008

Registration

Registrar
Xin Net Technology Corporation
Created
2005-08-26
Expires
2028-08-26 830 days left
Updated
2025-12-29
Name servers
  • ns3.dnsv4.com
  • ns4.dnsv4.com

DNS records live

NS
  • ns3.dnsv4.com
  • ns4.dnsv4.com
MX
  • 10 pharmablock-com.mail.protection.outlook.com
TXT
  • google-site-verification=ob8SYddA9aQg_zcQ_-9RyoM4vKviR2ypzE-WZBE2onQ
  • MS=ms27705471
  • blcqtjpkn8y48q7zdrn57k4w35g6cy3p

Email authentication strong

SPF
v=spf1 include:spf.protection.outlook.com -all
strict (-all)
DMARC
v=DMARC1; p=quarantine; rua=mailto:dmarc@pharmablock.com
policy: quarantine
DKIM
  • selector1: v=DKIM1; k=rsa; p=MIIBIjANBgkqhkiG9w0BAQEFAAOCAQ8AMIIBCgKCAQEAnX5TLuK93mwXwxOV30WRQpeL7e4uDUwy80+A2aakYUkBiw8eKgUygzXPgOumZ6JZgO9MYT5sPn1cql…
  • selector2: v=DKIM1; k=rsa; p=MIIBIjANBgkqhkiG9w0BAQEFAAOCAQ8AMIIBCgKCAQEAvQpti153bYTvjgyovZLnF/LwmLtL78LEljMPfdTFaAmTJcCss7F6L+l0R5dJE+SSi+xN7kF/aGd391…
selectors probed

Certificate (current)

GeoTrust G2 TLS CN RSA4096 SHA256 2022 CA1
from 2025-08-27 to 2026-08-27
Expires in 100 days

Full certificate history on crt.sh ↗

HTTP security headers

Header hygiene 30/100 Checked live page: https://pharmablock.com/

findings
  • missing HSTS
  • missing Content Security Policy
  • missing frame protection
  • missing content type protection
  • missing Referrer Policy
  • missing Permissions Policy

Links to (1)

Linked from (1)